FindTrial
Sign In

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01049321
Enrollment
36
Registered
2010-01-14
Start date
2008-12-31
Completion date
2009-12-31
Last updated
2010-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetic Patients

Keywords

Dietary Approach to Stop Hypertension, weight, coagulation, DASH eating pattern.

Brief summary

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Interventions

DIETARY_SUPPLEMENTDASH diet
DIETARY_SUPPLEMENTa usual diabetic diet

Sponsors

Shahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, Isfahan
CollaboratorUNKNOWN
Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
44 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Having type 2 diabetes

Exclusion criteria

* Having other chronic disease, hepatic or kidney disorders, cancer, hormone therapy

Design outcomes

Primary

MeasureTime frame
Cardio-metabolic risks6 months

Secondary

MeasureTime frame
Hepatic function6 months

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026